A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients - Bain,V.G.; Kaita,K.D.; Yoshida,E.M. (J Hepatol, 2006)